Later, it was demonstrated that activation of the Ras–MAPK–ETS2–p300 cascade leads to GSK-3β overexpression in pancreatic cancer cells (Zhang et al., 2011). This evidence concerns the gene EP300 and familial pancreatic carcinoma.